Search results for " alzheimer"

showing 10 items of 149 documents

Potential Roles of Peroxisomes in Alzheimer's Disease and in Dementia of the Alzheimer's Type

2012

In Alzheimer's disease (AD) and dementia of the Alzheimer's type (DAT), the role played by peroxisomes is not well known. Peroxisomes are present in all eukaryotic cells, with the exception of erythrocytes. They are involved in the β-oxidation process of long-chain fatty acids, very-long-chain fatty acids, and branched-chain fatty acids. They participate in the α-oxidation of phytanic acid, the biosynthesis of bile acids, and the breakdown of eicosanoids. Peroxisomes are also involved in the synthesis of specific fatty acids such as docosahexaenoic acid (DHA), which is essential for the brain and retina, and plasmalogens (PLGN), which play crucial roles in neural cells and are essential com…

carnitine-dependent enzymesPhytanic acidalzheimerplasmalogenMitochondrionBiologyfatty acidsModels Biologicaldhachemistry.chemical_compoundAlzheimer Diseaselipid metabolismPeroxisomesmedicineAnimalsHumansDementianeurodegenerative diseasesperoxisomeCarnitineCognitive declineNeuronsGeneral NeuroscienceBrainGeneral MedicineMetabolismPeroxisomemedicine.diseaseMitochondriaalzheimer; fatty acids; peroxisomes; alzheimer's disease; plasmalogen; dementia; neurodegenerative diseases; dha; peroxisome; lipid metabolism; carnitine-dependent enzymesPsychiatry and Mental healthClinical PsychologychemistryBiochemistryDocosahexaenoic acidalzheimer's diseaseGeriatrics and GerontologyOxidation-Reductiondementiamedicine.drugJournal of Alzheimer's Disease
researchProduct

(±)- BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channe…

2021

Multitarget-directed ligands (MTDLs) are considered a promising therapeutic strategy to address the multifactorial nature of Alzheimer's disease (AD). Novel MTDLs have been designed as inhibitors of human acetylcholinesterases/butyrylcholinesterases, monoamine oxidase A/B, and glycogen synthase kinase 3β and as calcium channel antagonists via the Biginelli multicomponent reaction. Among these MTDLs, (±)-BIGI-3h was identified as a promising new hit compound showing in vitro balanced activities toward the aforementioned recognized AD targets. Additional in vitro studies demonstrated antioxidant effects and brain penetration, along with the ability to inhibit the aggregation of both τ protein…

cholinesterasePhysiologyMonoamine oxidaseCognitive NeuroscienceLigandPharmacologyLigandsCalcium ChannelBiochemistry03 medical and health sciences0302 clinical medicineAlzheimer DiseaseIn vivoGSK-3HumansCholinesterasesCholinesterase InhibitorBiginelli reactionAlzheimer's disease; Biginelli reaction; calcium channel; cholinesterases; GSK 3β; MAO; Calcium Channel Blockers; Calcium Channels; Cholinesterase Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Ligands; Monoamine Oxidase; Alzheimer DiseaseMonoamine OxidaseGSK3B030304 developmental biologyCholinesterase0303 health sciencesGlycogen Synthase Kinase 3 betaVoltage-dependent calcium channelbiologyChemistryCalcium channelCell BiologyGeneral MedicineAlzheimer's diseaseCalcium Channel BlockersCalcium channel GSK 3β MAOMAObiology.proteinCalcium ChannelsCholinesterase InhibitorsGSK 3βMonoamine oxidase ACalcium Channel BlockerAlzheimer’s disease030217 neurology & neurosurgeryHuman
researchProduct

Starzenie się mózgu a choroba Alzheimera

2014

choroba Alzheimeraapolipoproteina Eizoformy ApoE4Alzheimer's diseaseapolipoprotein Eisoforms ApoE4
researchProduct

Voluntary Imitation in Alzheimer’s Disease Patients

2016

International audience; Although Alzheimer's disease (AD) primarily manifests as cognitive deficits, the implicit sensorimotor processes that underlie social interactions, such as automatic imitation, seem to be preserved in mild and moderate stages of the disease, as is the ability to communicate with other persons. Nevertheless, when AD patients face more challenging tasks, which do not rely on automatic processes but on explicit voluntary mechanisms and require the patient to pay attention to external events, the cognitive deficits resulting from the disease might negatively affect patients' behavior. The aim of the present study was to investigate whether voluntary motor imitation, i.e.…

cognitionAgingbehaviorsCognitive Neurosciencemedia_common.quotation_subject[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyInterpersonal communicationaction observationperceptionStimulus (physiology)frontotemporal dementiaApraxia050105 experimental psychologylcsh:RC321-571Developmental psychology03 medical and health sciences0302 clinical medicinevisuomotor integrationPerceptionmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal Researchmedia_commonmechanismsmotor imitationAction observation; Alzheimer's disease; Motor imitation; Movement execution; Social interaction; Aging; Cognitive Neuroscience05 social sciencesapraxiasocial interactiontoolCognitionAlzheimer's diseasemedicine.diseaseSocial relation[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]movement executionmovementCognitive imitationPsychologyAlzheimer’s disease030217 neurology & neurosurgeryNeuroscienceFrontotemporal dementiaCognitive psychologyFrontiers in Aging Neuroscience
researchProduct

Semantic inhibition and dementia severity in Alzheimer’s disease

2019

Semantic inhibition is often found to be impaired in Alzheimer’s disease (AD). The sentence completion task (Hayling test) was used to investigate whether it would be useful for differentiating mild AD from moderate AD. Method: Latency responses and error scores in the automatic and inhibition parts of the test were registered in these two groups of patients and in a group of healthy older participants. The types of errors were also analysed. Group differences were analysed by ANOVA. In addition, relationships with other neuropsychological tests were reported. Results: Participants with moderate AD performed worse than controls in both the automatic and inhibition sections, whereas particip…

demenciafunciones ejecutivasinhibición semánticaHayling taskSemantic inhibitionenfermedad de Alzheimertarea Haylingexecutive functionsAlzheimer’s diseasedementia
researchProduct

IL DOLORE NELLA DEMENZA

2010

demenza dolore alzheimer demenza vascolare
researchProduct

El papel del ejercicio físico en la inducción de BDNF y sus vías de señalización en el sistema nervioso central. Aplicación neurobiológica en modelos…

2014

La actividad física previene numerosas patologías y mejora muchos rasgos fisiopatológicos en diferentes enfermedades. El ejercicio ha sido asociado clásicamente con beneficios en desórdenes musculares y metabólicos. Sin embargo, los efectos del ejercicio en la función cerebral, especialidad conocida como “Neurobiología del ejercicio”, han cobrado gran importancia en los últimos años. Los efectos beneficiosos del ejercicio físico han sido establecidos en muchas enfermedades tales como la enfermedad de Alzheimer, el Parkinson, la esclerosis lateral amiotrófica, la esquizofrenia, el trastorno bipolar y los trastornos depresivos, entre otros. Estos hallazgos han llevado a utilizar el ejercicio …

factor neurotrófico derivado del cerebroentrenamiento físicoenfermedad de alzheimerUNESCO::CIENCIAS MÉDICASneuroplasticidad:CIENCIAS MÉDICAS [UNESCO]neurodegeneración
researchProduct

Biodistribution of Insulin-Nanogels in Mouse: A Preliminary Study for the Treatment of Alzheimer's Disease

2017

A growing body of evidence shows that Insulin, Insulin Receptor (IR) and IR signaling are involved in brain cognitive functions and their dysfunction is implicated in Alzheimer's disease (AD) neurodegeneration. Thus, administration of insulin could be a strategy for AD treatment. For this aim we have designed, synthesized and characterized a nanogel system (NG) that has been conjugated to insulin molecules (NG-In) to deliver the protein into the brain, as a tool for the development of a new therapy against AD. In our preclinical study in mice, intraperitoneal injection of fluorescent-labeled NG has allowed to determine the biodistribution of NG vs time in the whole body and its clearance th…

insulinBiodistributionmedicine.medical_treatmentIntraperitoneal injectionBiophysics02 engineering and technologyPharmacology010402 general chemistrySettore BIO/09 - Fisiologia01 natural sciencesintranasal administrationnanogelsTreatment of Alzheimer's DiseasemedicineDistribution (pharmacology)biologybusiness.industryInsulinNeurodegeneration021001 nanoscience & nanotechnologymedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)0104 chemical sciencesInsulin receptorImmunologybiology.proteinNasal administrationSettore CHIM/07 - Fondamenti Chimici Delle TecnologieAlzheimer disease0210 nano-technologybusinessNanogelBiophysical Journal
researchProduct

Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease

2007

Abstract Background : Recent evidence suggests that duloxetine may increase the effect of warfarin, thereby increasing the possibility of bleeding. However, a MEDLINE search for articles published between 1980 and May 2007 (terms: duloxetine , anticoagulants , acenocoumarol , and interaction ; no language restriction) did not yield any reports of an interaction between concomitant use of duloxetine and acenocoumarol. Objective : The aim of this study was to describe a potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease. The possible mechanism of this potential interaction is examined. Case summary : This report presents the case of a 63…

medicine.drug_classThiophenesDuloxetine Hydrochloridechemistry.chemical_compoundAlzheimer DiseasemedicineHumansDuloxetineDrug InteractionsPharmacology (medical)International Normalized Ratioduloxetine acenocoumarol international normalized ratio Alzheimer’s diseasePharmacologyAcenocoumarolbusiness.industryAcenocoumarolAnticoagulantWarfarinAnticoagulantsMiddle AgedDrug interactionDiscontinuationchemistryAnesthesiaConcomitantFemaleSettore MED/26 - NeurologiabusinessReuptake inhibitorSelective Serotonin Reuptake Inhibitorsmedicine.drugClinical Therapeutics
researchProduct

Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 …

2020

Background: Alkaline phosphatase has been found on neuronal membranes and plasma alkaline phosphatase (ALP) activity increases during brain injury and cerebrovascular diseases, suggesting that its levels may reflect the neuronal loss. It is known that ALP is higher in subjects affected by Alzheimer’s dementia and inversely correlated with cognitive functions. No study has investigated the relationship between ALP and cognitive functions in old-age subject with pre-clinical cognitive impairment. Methods: This is a cross-sectional study with data gathered from the ReGAl 2.0 project (Rete Geriatrica Alzheimer-Geriatric Network on Alzheimer’s disease), a large Italian multicentric clinical-base…

medicine.medical_specialtyAgingGeriatric medicineAging Biochemistry Cognition Dementia Geriatric medicine Aged Alkaline Phosphatase Cognition Cross-Sectional Studies Humans Italy Neuropsychological Tests Alzheimer Disease Cognitive DysfunctionPopulationNeuropsychological TestsBiochemistry03 medical and health sciences0302 clinical medicineCognitionAlzheimer DiseaseInternal medicinemedicineMemory spanDementiaHumansCognitive Dysfunction030212 general & internal medicineCognitive declineeducationAgededucation.field_of_studybusiness.industryNeuropsychologyCognitionmedicine.diseaseAlkaline PhosphataseEndocrinologyCross-Sectional StudiesItalyCohortAlkaline phosphataseSettore MED/26 - NeurologiaDementiaGeriatrics and Gerontologybusiness030217 neurology & neurosurgery
researchProduct